Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Doxorubicin-induced cardiotoxicity: causative factors and possible interventions
Isobel C Jones, Crispin R. Dass
Journal of Pharmacy and Pharmacology (2022) Vol. 74, Iss. 12, pp. 1677-1688
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Lipid-based nanoparticles as drug delivery carriers for cancer therapy
Ibtesam Waheed, Anwar Ali, Huma Tabassum, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 20
Emerging role of exosomes in cancer therapy: progress and challenges
Jiale Li, Jiachong Wang, Zigui Chen
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Iron Load Toxicity in Medicine: From Molecular and Cellular Aspects to Clinical Implications
George J. Kontoghiorghes
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12928-12928
Open Access | Times Cited: 24
Exosomal miR-9-5p derived from iPSC-MSCs ameliorates doxorubicin-induced cardiomyopathy by inhibiting cardiomyocyte senescence
Huifeng Zheng, Xiaoting Liang, Baojuan Liu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Synergistic Effects of Temozolomide and Doxorubicin in the Treatment of Glioblastoma Multiforme: Enhancing Efficacy through Combination Therapy
Laxmi Dhungel, Mandy E. Rowsey, Cayla Harris, et al.
Molecules (2024) Vol. 29, Iss. 4, pp. 840-840
Open Access | Times Cited: 11
A Triple‐Responsive Polymeric Prodrug Nanoplatform with Extracellular ROS Consumption and Intracellular H2O2 Self‐Generation for Imaging‐Guided Tumor Chemo‐Ferroptosis‐Immunotherapy
Yongjuan Li, Yongjian Cao, Kunru Ma, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 16
Closed Access | Times Cited: 7
Doxorubicin-mediated cardiac dysfunction: Revisiting molecular interactions, pharmacological compounds and (nano)theranostic platforms
Xiaofeng Li
Environmental Research (2023) Vol. 234, pp. 116504-116504
Closed Access | Times Cited: 20
Recent Advances in Mitochondrial Fission/Fusion-Targeted Therapy in Doxorubicin-Induced Cardiotoxicity
Chayodom Maneechote, Siriporn C. Chattipakorn, Nipon Chattipakorn
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1182-1182
Open Access | Times Cited: 16
The m6A demethylase fat mass and obesity-associated protein mitigates pyroptosis and inflammation in doxorubicin-induced heart failure via the toll-like receptor 4/NF-κB pathway
Weiling Tu, Xiao Huang, Song‐Tao Liu, et al.
Cardiovascular Diagnosis and Therapy (2024) Vol. 14, Iss. 1, pp. 158-173
Open Access | Times Cited: 6
Cardioprotective Effect of Hydroalcohol Extract of Andaliman (Zanthoxylum acanthopodium DC.) Fruits on Doxorubicin-Induced Rats
Aminah Dalimunthe, Denny Satria, Panal Sitorus, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 359-359
Open Access | Times Cited: 5
Design and implication of a breast cancer-targeted drug delivery system utilizing the Kisspeptin/GPR54 system
YaoYan Nie, Y. Wei, Yuhuan Zhang, et al.
International Journal of Pharmaceutics (2025) Vol. 670, pp. 125154-125154
Closed Access
Cardiotoxicity of Anticancer Drugs
И. В. Майбородин, A. O. Shumeikina, В. И. Майбородина, et al.
Antibiot Khimioter = Antibiotics and Chemotherapy (2025) Vol. 69, Iss. 9-10, pp. 91-107
Open Access
Exosomes and solid cancer therapy: where are we now?
Tomáš Zemánek, Ľuboš Danišovič, Andreas Nicodemou
Medical Oncology (2025) Vol. 42, Iss. 3
Open Access
Advances in the activity of resveratrol and its derivatives in cardiovascular diseases
Yaling Peng, Xing Zheng, Si Zhang, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 2
Closed Access
Nanobiotechnology: traditional re-interpreting personalized medicine through targeted therapies and regenerative solutions
S. Chattopadhyay, Arunava Goswami, Moumita Sil
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Mitigation of Cardiovascular Disease and Toxicity through NRF2 Signalling
James A. Roberts, Richard D. Rainbow, Parveen Sharma
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6723-6723
Open Access | Times Cited: 13
Bibliometric and visual analysis of doxorubicin-induced cardiotoxicity
Xiaoxiao Lin, Guomin Wu, Shuai Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Oxyresveratrol in Breast Cancer Cells: Synergistic Effect with Chemotherapeutics Doxorubicin or Melphalan on Proliferation, Cell Cycle Arrest, and Cell Death
Carlos Luan Alves Passos, Christian Ferreira, Aline Gabrielle Alves de Carvalho, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 873-873
Open Access | Times Cited: 4
M2b macrophages protect against doxorubicin induced cardiotoxicity via alternating autophagy in cardiomyocytes
Sida Chen, Yang Huang, Suiqing Huang, et al.
PLoS ONE (2023) Vol. 18, Iss. 7, pp. e0288422-e0288422
Open Access | Times Cited: 11
Ethanolic extract from leaves of tithonia diversifolia induces apoptosis in HCT-116 cells through oxidative stress
Maria Fernanda Madrid Mendoza, Jéssica Almeida Mota, Fátima de Cássia Evangelista de Oliveira, et al.
Journal of Toxicology and Environmental Health (2024) Vol. 87, Iss. 7, pp. 275-293
Closed Access | Times Cited: 3
AP39, a novel mitochondria-targeted hydrogen sulfide donor ameliorates doxorubicin-induced cardiotoxicity by regulating the AMPK/UCP2 pathway
Bin Zhang, Yangxue Li, Ning Liu, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0300261-e0300261
Open Access | Times Cited: 3
Multiscale mapping of transcriptomic signatures for cardiotoxic drugs
Jens Hansen, Yuguang Xiong, Mustafa M. Siddiq, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Myocardium-targeted liposomal delivery of the antioxidant peptide 8P against doxorubicin-induced myocardial injury
Mei-Jun Zhao, Chang Liu, Zhenye Liu, et al.
International Journal of Pharmaceutics (2024) Vol. 663, pp. 124569-124569
Closed Access | Times Cited: 2
Pregnenolone Inhibits Doxorubicin-Induced Cardiac Oxidative Stress, Inflammation, and Apoptosis—Role of Matrix Metalloproteinase 2 and NADPH Oxidase 1
Mohamed A. Morsy, Seham A. Abdel-Gaber, Sahar A. Mokhemer, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 665-665
Open Access | Times Cited: 7
Self-assembly of maltose-albumin nanoparticles for efficient targeting delivery and therapy in liver cancer
Lu Wang, Yi‐Rui Wu, Niuniu Yang, et al.
International Journal of Biological Macromolecules (2023) Vol. 258, pp. 128691-128691
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top